Current tuberculosis incidence among children; medicines for prevention and diagnosis of TB

The article analyses main epidemiological parameters of tuberculosis (TB) in children and adolescents in Russia. It was demonstrated that the incidence rate in this population, though decreasing, is still high. The disease incidence in children and adolescents arising from contacts with people with active TB is 30 and 25 times higher than the overall incidence rate in children and adolescents in Russia, respectively. Analysis of TB lesions in a major proportion of children and adolescents shows multi-drug resistant strains of Mycobacteria tuberculosis (MTB), and this calls for revision of approaches to preventive actions for this population. The tuberculine Mantoux test is of limited value when it comes to diagnosing TB in adolescents. Screening in adolescents and children older than 7 years is performed using Diaskintest® containing two MBT-specific antigens. Specific TB prevention for newborns is performed by vaccination with BCG and BCG-M living vaccines. The product was modified by a 30 % reduction of the number of BCG living cells per 1 mg of vaccine in order to reduce postvaccinal complications largely associated with residual virulence of the BCG substrain. Since 2012 BCG vaccine lots have been standardized to contain from 500 thousand to 1 million viable BCG cells per BCG vaccine dose and from 375 thousand to 575 thousand viable BCG cells per BCG-M vaccine dose.

заболеваемость туберкулезом, микобактерии туберкулеза (МБТ), скрининговые иммунологические пробы (Манту и диаскинтест), вакцина БЦЖ, осложнения вакцинации, tuberculosis incidence, Mycobacteria tuberculosis (MTB), immunological screening tests (Mantoux and Diaskintest), BCG vaccine, postvaccinal complications

1. Global tuberculosis report 2016. 1. Tuberculosis — epidemiology. 2. Tuberculosis, Pulmonary — prevention and control.

2. Aksenova VA. Tuberculosis in children and adolescents in Russia at the beginning of the 21st century. Medical Alliance 2013; (1): 46–9 (in Russian).

3. Bogorodskaya EM, Belilovsky EM, Puchkov KG, Senchikhina OYu, Shamuratova LF. The incidence of tuberculosis in children of an early age in the city of Moscow and the factors influencing it. Tuberculosis and Socially Significant Diseases 2014; (5): 15–22 (in Russian).

4. Barmina NA, Baryshnikova LA, Shurygin AA, Reichardt VV. Screening of children and adolescents of III, IV and V health groups with the new medical test. Tuberculosis and Lung Diseases 2015; (5): 40–1 (in Russian).

5. Slogotskaya LV, Bogorodsakaya EM, Levi DT, Seltsovsky PP. Comparison of efficacy of Diaskintest®, a skin test with a recombinant tuberculosis allergen, used for 10 years and Mantoux tuberculin sensitivity test used for 110 years. BIOpreparations. Prevention, Diagnosis, Treatment 2017; 17(2): 67–77 (in Russian).

6. Aksenova VA, Sevostyanova TA. Tuberculosis in children and adolescents in Russia. Lechaschi Vrach 2013; (1): 35–9 (in Russian).

7. Slogotskaya LV, Ivanova DA, Kochetkov YaA, Kulikovskaya NV, Vaneeva TV, Filippov AV. Comparative results of skin test with recombinant CFP-10/ESAT-6 fusion protein preparation and laboratory test QuantiFERON-GIT. Tuberculosis and Lung Diseases 2012; (10): 27–32 (in Russian).

8. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, et al. Interferon- release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011; 37(1): 88–99.

9. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007; 131(5): 1424–34.

10. Poddubnaya LV, Shilova EP, Stepchenko IM, Kononenko VG. Epidemiologic factors and immunoassays in the formation of tuberculosis risk groups. Tuberculosis and Lung Diseases 2015; (5): 153–4 (in Russian).

11. Order of the Ministry of Health of the Russian Federation of 29.12.2014 ¹ 951 «On approval of methodological recommendations for diagnosis and treatment of respiratory tuberculosis».

12. Baily GV. Tuberculosis prevention Trial, Madras. Indian J Med Res. 1980; 72 Suppl: 1–74.

13. Aksenova VA, Levi DT. Tuberculosis vaccines. In: Zverev VV, Semenov BF, Khaitov RM, eds. Vaccines and vaccination. National guidance. M.: GEOTAR-Media; 2011. P. 371–411 (in Russian).

14. Levi DT, Aleksandrova NV, Sevostyanova TA, Podlipaeva IV, Aksenova VA, Rukhamina ML. Complications after vaccination against tuberculosis. Tuberculosis and Lung Diseases 2013; (9): 10–5 (in Russian).

15. Guidance for national tuberculosis programmes on the management of tuberculosis in children Second Edition 2014 https://goo.gl/ mDCvXy